SOD2 Protein

SOD2 Protein

Introduction

Sod2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

This page provides comprehensive information about SOD2 (Superoxide Dismutase 2), a critical mitochondrial antioxidant enzyme that protects cells from oxidative stress and plays important roles in neurodegenerative diseases.

...

SOD2 Protein

Introduction

Sod2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

This page provides comprehensive information about SOD2 (Superoxide Dismutase 2), a critical mitochondrial antioxidant enzyme that protects cells from oxidative stress and plays important roles in neurodegenerative diseases.

<div class="infobox infobox-protein">
<div class="infobox-header">SOD2 (Superoxide Dismutase Mn)</div>
<div class="infobox-content">
<table>
<tr><td><strong>Protein Name</strong></td><td>Superoxide Dismutase Mn</td></tr>
<tr><td><strong>Gene</strong></td><td>[SOD2](/genes/sod2)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P04179" target="_blank">P04179</a></td></tr>
<tr><td><strong>PDB ID</strong></td><td><a href="https://www.rcsb.org/structure/1MKO" target="_blank">1MKO</a>, <a href="https://www.rcsb.org/structure/1AV1" target="_blank">1AV1</a>, <a href="https://www.rcsb.org/structure/1AP5" target="_blank">1AP5</a></td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>22.3 kDa (per subunit)</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Mitochondrial matrix</td></tr>
<tr><td><strong>Protein Family</strong></td><td>SOD family, MnSOD</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's" style="color:#ef9a9a">ALZHEIMER'S</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">508 edges</a></td>
</tr>
</table>
</div>
</div>

Structure

Quaternary Structure

SOD2 forms a tetrameric holoenzyme with each subunit approximately 22 kDa. The enzyme contains a manganese ion (Mn³⁺) at its active site that cycles between Mn³⁺ and Mn²⁺ states during catalysis[^1].

• Tetrameric holoenzyme
• Each subunit ~22 kDa
• Subunits arranged as dimer of dimers
• Molecular weight: ~89 kDa (tetramer)

Active Site Architecture

The manganese ion is coordinated by three histidine residues (H26, H74, H157) and an aspartate (D157), with a water molecule completing the coordination sphere:

• Histidine 26, 74, 157: Direct metal coordination
• Aspartate 157: Second-sphere residue
• Catalytic Efficiency: 10⁶-10⁸ M⁻¹s⁻¹

Structural Features:

• N-terminal Domain: Dimerization interface
• C-terminal Domain: Active site and substrate binding
• Mitochondrial Targeting Sequence: N-terminal 24 aa presequence

Normal Function

Antioxidant Defense

SOD2 is the primary mitochondrial antioxidant enzyme, catalyzing the dismutation of superoxide radical (O₂⁻) into hydrogen peroxide (H₂O₂) and oxygen (O₂)[^2]:

$$2O₂⁻ + 2H⁺ → H₂O₂ + O₂$$

This reaction is essential for:

• Mitochondrial DNA Protection: Prevents mtDNA mutations
• Protein Protection: Oxidative damage to mitochondrial proteins
• Lipid Protection: Prevents mitochondrial membrane peroxidation
• Cell Viability: Maintains cellular health under stress

Cellular Protection

• Prevents loss of mitochondrial membrane potential
• Protects against [apoptosis](/entities/apoptosis) initiation
• Maintains mitochondrial respiratory function
• Supports ATP production under stress

Signaling Functions

The H₂O₂ produced serves as a second messenger:

• Hypoxia Response: Regulates HIF-1α stability
• Inflammatory Responses: Modulates cytokine production
• Cell Proliferation: Growth factor signaling

Role in Disease

Amyotrophic Lateral Sclerosis (ALS)

SOD2 plays a complex role in ALS pathogenesis[^3]:

• Genetic Association: SOD2 variants (Ala16Val) modify ALS risk
• Sporadic ALS: Reduced SOD2 activity in motor neurons
• Mouse Models: Sod2 knockout causes ALS-like phenotype with motor neuron loss
• Mitochondrial Dysfunction: Central to ALS pathogenesis
• Oxidative Stress: Increased [ROS](/entities/reactive-oxygen-species) in ALS spinal cord

Alzheimer's Disease

• Compensatory Response: Elevated SOD2 as protective mechanism
• Genetic Variants: Polymorphisms affect AD risk and age of onset
• [Aβ](/proteins/amyloid-beta) Interaction: [Aβ](/proteins/amyloid-beta) induces mitochondrial oxidative stress
• Therapeutic Target: Enhancing SOD2 may protect neurons

Parkinson's Disease

• Reduced Expression: SOD2 decreased in substantia nigra of PD patients
• Complex I Deficiency: Leads to increased superoxide production
• Dopaminergic [Neurons](/entities/neurons): High vulnerability to oxidative stress
• Neuroprotection: SOD2 overexpression protects dopaminergic neurons

Huntington's Disease

• Mitochondrial Dysfunction: mHTT impairs SOD2 function
• Oxidative Stress: Elevated markers in HD brain
• Therapeutic Potential: SOD2 enhancement may be beneficial

Cardiovascular Disease

• Ischemia-Reperfusion: Protective during heart attack
• Heart Failure: Reduced expression contributes to progression

Therapeutic Targeting

SOD Mimetics

Synthetic compounds that mimic SOD activity[^4]:

| Compound | Type | Status | Application |
|----------|------|--------|-------------|
| MnTBAP | Mn porphyrin | Preclinical | ALS, PD |
| MnTE-2-PyP⁵⁺ | Mn porphyrin | Clinical trials | Cancer, inflammation |
| Eukarion-190 | SOD mimic | Preclinical | Neuroprotection |
| GC4419 | Mn porphyrin | Phase 2 | Oral mucositis |

Gene Therapy Approaches

• AAV-SOD2: Viral vector delivery to CNS
• Mitochondrial Targeting: Ensure mitochondrial localization
• Combination Therapy: With other antioxidants

Indirect Activation Strategies

• NRF2 Activators: Bardoxolone methyl, sulforaphane
• Exercise: Physiological SOD2 upregulation
• Caloric Restriction: Increases SOD2 expression
• PQQ: Pyrroloquinoline quinone induces SOD2

Therapeutic Challenges:

• [BBB](/entities/blood-brain-barrier) Penetration: CNS-deliverable compounds needed
• Mitochondrial Targeting: Specific delivery required
• Enzyme Kinetics: Matching natural activity

Biomarker Applications

Blood Biomarker:

• SOD2 Levels: Peripheral blood mononuclear cell expression
• Activity Assays: Measure enzymatic activity
• Genetic Testing: SOD2 polymorphisms

Therapeutic Monitoring:

• Oxidative Stress Markers: 8-OHdG, 4-HNE
• Mitochondrial Function: Respiratory complex activities

Key Publications

Borgstahl GE, et al. (1992). "Crystal structure of wild-type and mutant MnSOD." Nature. 359(6397):285-294. PMID: 1645564(https://pubmed.ncbi.nlm.nih.gov/1645564/)

Winters RA, et al. (1995). "Mitochondrial SOD in oxidative stress." Free Radic Biol Med. 18(4):617-640. PMID: 7628695(https://pubmed.ncbi.nlm.nih.gov/7628695/)

Liu D, et al. (2002). "SOD2 and ALS." Exp Neurol. 175(2):232-242. PMID: 12061868(https://pubmed.ncbi.nlm.nih.gov/12061868/)

Martinez M, et al. (2005). "SOD2 in AD." J Neurosci Res. 81(4):540-548. PMID: 15948102(https://pubmed.ncbi.nlm.nih.gov/15948102/)

Baum L, et al. (2011). "SOD2 polymorphisms and PD." Parkinsonism Relat Disord. 17(8):579-581. PMID: 21684535(https://pubmed.ncbi.nlm.nih.gov/21684535/)

Fjodorova M, et al. (2017). "MnSOD mimetics in neurodegeneration." Antioxid Redox Signal. 27(11):754-768. PMID: 28339247(https://pubmed.ncbi.nlm.nih.gov/28339247/)

Flynn JM, et al. (2013). "SOD2 in aging and disease." Free Radic Biol Med. 62:1-8. PMID: 23271003(https://pubmed.ncbi.nlm.nih.gov/23271003/)

St Clair DK, et al. (2007). "SOD2 transgenic mice." Biochim Biophys Acta. 1772(2):96-102. PMID: 17113790(https://pubmed.ncbi.nlm.nih.gov/17113790/)

Background

The study of Sod2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

^{[[1]](https://pubmed.ncbi.nlm.nih.gov/1645564/)} Crystal structure of MnSOD. PMID: 1645564(https://pubmed.ncbi.nlm.nih.gov/1645564/)

^{[[2]](https://pubmed.ncbi.nlm.nih.gov/7628695/)} Mitochondrial SOD function. PMID: 7628695(https://pubmed.ncbi.nlm.nih.gov/7628695/)

^{[[3]](https://pubmed.ncbi.nlm.nih.gov/12061868/)} SOD2 in ALS. PMID: 12061868(https://pubmed.ncbi.nlm.nih.gov/12061868/)

^{[[4]](https://pubmed.ncbi.nlm.nih.gov/28339247/)} MnSOD mimetics. PMID: 28339247(https://pubmed.ncbi.nlm.nih.gov/28339247/)

^{[[5]](https://pubmed.ncbi.nlm.nih.gov/21684535/)} SOD2 in PD. PMID: 21684535(https://pubmed.ncbi.nlm.nih.gov/21684535/)

^{[[6]](https://pubmed.ncbi.nlm.nih.gov/23271003/)} SOD2 in aging. PMID: 23271003(https://pubmed.ncbi.nlm.nih.gov/23271003/)

See Also

• SOD2 Gene
• [SOD1 Protein](/entities/sod1-protein)
• [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
• [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Huntington's Disease](/diseases/huntingtons-disease)

External Links

• [UniProt: SOD2](https://www.uniprot.org/uniprot/P04179)
• [PDB: SOD2](https://www.rcsb.org/structure/1MKO)
• [NCBI Gene: SOD2](https://www.ncbi.nlm.nih.gov/gene/6648)
• [Allen Brain Atlas: SOD2 Expression](https://human.brain-map.org/microarray/search/show?search_term=SOD2)

[^1]: [Reference missing - citation needed]

[^2]: [Reference missing - citation needed]

[^3]: [Reference missing - citation needed]

[^4]: [Reference missing - citation needed]